RUSSELL FRANK CO/ - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 91 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q2 2014. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
RUSSELL FRANK CO/ ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q4 2015$79,000
+132.4%
27,998
+160.2%
0.00%
Q3 2015$34,000
-64.6%
10,760
-33.3%
0.00%
Q2 2015$96,000
+3100.0%
16,140
+6597.1%
0.00%
Q1 2015$3,000
-99.8%
241
-99.9%
0.00%
-100.0%
Q4 2014$1,768,000
+167.9%
187,672
+118.5%
0.00%
+200.0%
Q3 2014$660,000
-19.3%
85,893
-21.0%
0.00%0.0%
Q2 2014$818,000
+5742.9%
108,749
+2047.9%
0.00%
Q3 2013$14,0005,063
+8941.1%
0.00%
Q2 2013$0560.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q2 2014
NameSharesValueWeighting ↓
Sageview Capital 2,223,339$5,603,0001.59%
Orbimed Advisors 2,320,800$5,848,0000.09%
F&C Asset Management plc 1,854,808$4,665,0000.06%
SPHERA FUNDS MANAGEMENT LTD. 56,500$142,0000.04%
Yakira Capital Management, Inc. 11,957$30,0000.03%
Spectrum Management Group, LLC 10,000$25,0000.02%
Weiss Multi-Strategy Advisers LLC 41,152$104,0000.00%
WOLVERINE ASSET MANAGEMENT LLC 30,000$75,0000.00%
PUTNAM INVESTMENTS LLC 129,762$327,0000.00%
Partnervest Advisory Services LLC 220$1,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders